# EDGAR Filing Document

**Accession Number:** 0001425450
**File Stem:** 0001425450-25-000090
**Filing Date:** 2025-8
**Character Count:** 9502
**Document Hash:** 47f2f02a0628963120c3c51e25f291f4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001425450-25-000090.hdr.sgml**: 20250805

**ACCESSION NUMBER**: 0001425450-25-000090

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250805

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250805

**DATE AS OF CHANGE**: 20250805

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ORTHOPEDIATRICS CORP
- **CENTRAL INDEX KEY:** 0001425450
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 261761833
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38242
- **FILM NUMBER:** 251184795

**BUSINESS ADDRESS:**
- **STREET 1:** 2850 FRONTIER DRIVE
- **CITY:** WARSAW
- **STATE:** IN
- **ZIP:** 46582
- **BUSINESS PHONE:** 574-268-6379

**MAIL ADDRESS:**
- **STREET 1:** 2850 FRONTIER DRIVE
- **CITY:** WARSAW
- **STATE:** IN
- **ZIP:** 46582

?xml version='1.0' encoding='ASCII'? kids-20250805

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**______________________**

**FORM 8-K**

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**______________________**

Date of Report (Date of earliest event reported): **August 5, 2025**

---

| |
|:---|
| **OrthoPediatrics Corp.** |
| (Exact name of registrant as specified in its charter) |

---

---

| |
|:---|
| **Delaware** |
| (State or other jurisdiction of incorporation) |

---

---

| | |
|:---|:---|
| **001-38242** | **26-1761833** |
| (Commission File Number) | (I.R.S. Employer Identification Number) |

---

---

| | |
|:---|:---|
| **2850 Frontier Drive**<br>**Warsaw, Indiana** | **46582** |
| (Address of principal executive offices) | (Zip Code) |

---

Registrant's telephone number, including area code: **(574) 268-6379**

---

| |
|:---|
| **Not Applicable** |
| (Former name or former address, if changed since last report) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.00025 par value per share | KIDS | Nasdaq Global Market |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act (17 CFR 230.405) or Rule 12b-2 under the Exchange Act (17 CFR 240.12b-2).

Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ◻

------

**ITEM 7.01. REGULATION FD DISCLOSURE.**

On August 5, 2025, OrthoPediatrics Corp. ("the Company") issued a press release announcing the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") division with multiple new clinics and entry into two new territories. A copy of the press release is furnished as Exhibit 99.1 to this Current Report.

The Company does not intend for this Item 7.01 or Exhibit 99.1 to be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

**ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.** 

---

| | | |
|:---|:---|:---|
| **(d)** | **Exhibits** | |
| | **<u>Exhibit No.</u>** | **<u>Description</u>** |
| | <u>[99](opsbclinicexpansioniiv4_.htm)[.1](opsbclinicexpansioniiv4_.htm)</u> | <u>[Press release dated August 5, 2025, issued by OrthoPediatrics Corp.](opsbclinicexpansioniiv4_.htm)</u> |
| | 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

\* \* \* \* \* \*

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: August 5, 2025 |  |  |
|  | OrthoPediatrics Corp. | OrthoPediatrics Corp. |
|  | By: | /s/ Daniel J. Gerritzen |
|  |  | Daniel J. Gerritzen, <br>General Counsel and Secretary |

---

## Exhibit 99.1

![](opsbclinicexpansioniiv4_001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2850 Frontier Drive \| Warsaw, IN 46582 Ph: 574.268.6379 \| Fax: 574.268.6302 www.orthopediatrics.com OrthoPediatrics Corp. Announces Continued Expansion of Specialty Bracing Division Into New Territories with Multiple Clinics Warsaw, IN – August 5, 2025 – OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") division with multiple new clinics and entry into two new territories. The expansion of the OPSB division includes rapid expansion of greenfield clinic locations in California, Ohio, and Colorado. • Entered a new territory with OPSB's first clinic in California. The Los Angeles market provides access to millions of potential pediatric and adolescent patients. • Opened a new clinic in Dayton, OH, providing skilled clinicians within Dayton Children's Hospital and expanding the Ohio territory. • Added new clinics and experienced clinicians to cover the expansive Denver, CO territory. OPSB continues to expand through Acquihire opportunities by adding two new operations in New York and Ireland. • The greater New York City operation added multiple patient locations to the existing two clinics; all new clinics are located within major Children's Hospital centers. This strategic position will allow a seamless synergy between the clinicians and pediatric surgeons. • Ireland represents both a new territory and OPSB's first international market. This location is complimentary to OrthoPediatrics' strong implant business presence in one of the country's largest pediatric hospitals and provides opportunities to expand to additional Ireland based clinics and beyond across the European region. Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, "We are thrilled to announce this continued expansion as we are slightly ahead of our planned entry into 4 new target markets in 2025. Our vision to provide better bracing and O&P care to kids across the world is materializing by providing access to millions of potential new patients. I continue to be impressed by the response from surgeons, partnering hospitals, O&P clinicians, and parents, we are clearly filling an unmet need. Our impressive clinical team continues to grow, adding new team members while they increase their knowledge in the pediatric and adolescent space". Michael C. Albert MD, Division Chief of Pediatric Orthopedics at Dayton Children's Hospital shared in the excitement, "OrthoPediatrics has always been dedicated to the needs of children and this next step forward, focusing on bracing and O&P care, advances this mission. Their dedication to this space and expanding patient access is key. Partnering with OPSB to bring O&P care on-site will greatly benefit all our patients and our community. We are extremely happy to have them here". About OrthoPediatrics Corp. Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics' global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States.

------

![](opsbclinicexpansioniiv4_002.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2850 Frontier Drive \| Warsaw, IN 46582 Ph: 574.268.6379 \| Fax: 574.268.6302 www.orthopediatrics.com For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com. Investor Contact Philip Trip Taylor Gilmartin Group philip@gilmartinir.com 415-937-5406

------